Danaher Corporation

1990 Danaher acquires Easco Hand Tools Inc.[10] 1991 Danaher is selected as exclusive supplier of handtools for Sears. 1994 Danaher acquires the tool company Armstrong- makers of tool brands Armstrong, Allen, and others. Since 1999 Danaher owns 100% of Hach company, broadening the portfolio of chemical, mainly water and wastewater, analytics also with the German company Lange.

UK-based West Instruments provides control and measurement instrumentation and services for the global industrial and process markets. German instrumentation manufacturer PMA was added to the Industrial Controls Group in 2005 and enhances the range of control and measurement instrumentation.

In July 2005, Danaher Announces Definitive Agreement To Acquire Leica Microsystems.[11] The company manufactures a broad range of products for numerous applications requiring microscopic imaging, measurement and analysis. It also offers management systems in the areas of Life Science including biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.

In early 2007 Danaher acquired Australian Pathology Instrument and Engineering company Vision Systems Limited.[12] Also in 2007, Danaher made its largest acquisition to date, the purchase of Tektronix, Inc. for US$2.85 billion.[13][14]

In 2009 Danaher purchased the Analytical Technologies business unit of Canadian Life Sciences company MDS, Inc. for US$650 million.[15] In a separate, but related transaction, Danaher agreed with Life Technologies Corporation (Nasdaq: LIFE) to acquire the remaining 50% ownership position in AB SCIEX for US$450 million, leaving Danaher as outright owner of AB SCIEX and Molecular Devices. The aggregate purchase price for the combined transactions is $1.1 billion.[16]

In 2011, Danaher acquired Beckman Coulter[17] and sold Accu-sort to Datalogic.

In October 2012, Danaher Corporation and Cooper Industries agreed to sell their joint venture, Apex Tool Group, to Bain Capital for a fee of around $1.6 billion.[18] In December 2012 Danaher Corporation acquired Navman Wireless, a provider of on-demand fleet and asset management technology.[19]

In September 2014, Danaher Corp announced its intention to buy Nobel Biocare for $2.2 billion.[20] In October 2014, Danaher Corp announced it would be combining its communications unit with NetScout Systems.[21] The action was completed in July 2015[22]

In May 2015, Danaher Corp announced the acquisition of Pall for $13.8 billion,[23] which was completed in August 2015.[24]

In June 2016, Danaher spun off several subsidiaries, including Matco and AMMCO-COATS, to create Fortive.[25] In September of the same year, the company announced it would acquire Cepheid for $4 billion (including debt).[26]

In October 2016, Danaher Corporation acquired Phenomenex for $700 million to expand its life sciences space.[27]

In October 2017, Danaher Corp announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS).[28] It was announced that IDBS would become part of Danaher's life sciences platform.[29]

In 2017, Danaher recorded $18.3 billion in revenue.[30]

In March 2018, the business announced it would acquire Integrated DNA Technologies for an undisclosed price.[31]

In July 2018, Danaher announced its intention to spin off its $2.8 billion Dental segment, into an independent publicly traded company.[32]

In October 2019, Danaher announced it has signed an agreement to sell its biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses to Sartorius AG for approximately $750 million. The combined revenue of the businesses was approximately $140 million in 2018.[33]

In December 2019, Danaher completed the corporate spin-off of Envista, its dental unit.[34]

On Monday, March 2, 2020, Dr. Stephen Hahn, the F.D.A.’s commissioner, said that the agency had taken actions to allow private labs and companies to begin making their own coronavirus tests in order to greatly expand the U.S. capacity to test for the virus. Dr. Hahn went on to note, "There will be — the estimates we’re getting from industry right now, by the end of this week, close to a million tests will be able to be performed."[35] The following morning, a spokeswoman for the U.S. Department of Health and Human Services noted that Dr. Hahn was referring to tests being produced by an outside manufacturer, Integrated DNA Technologies. IDT is a division of Danaher which was acquired in early 2019.[36]

In March 2020, Danaher acquired Cytiva, the biopharma business of the General Electric Life Sciences division, for $21.4 billion. The unit makes equipment for the research and manufacture of pharmaceuticals.[37]